IRIDEX consensus paper investigates best practices for MicroPulse transscleral therapy for glaucoma
January 03, 2022
Robert J. Noecker, MD, MBA, discusses the IRIDEX consensus paper regarding MicroPulse transscleral therapy for glaucoma at AAO 2021.
© 2022 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
AAO
Exploring ancillary testing orders by retinal specialists according to the IRIS registry
January 06, 2022
Ted Leng, MD, discusses his IRIS Registry analysis presentation regarding variations in vitreoretinal physician utilization of ancillary testing.
ARTEMIS study results point to successful IOP lowering with bimatoprost implant
December 30, 2021
At AAO, AbbVie presented results from the ARTEMIS study, showcasing IOP lowering that extends beyond the original 20-month timeframe.
Updates on treatment of wet AMD and DME with brolucizumab
December 28, 2021
Jill Hopkins, MD, discusses results from phase 3a of the Merlin trial for brolucizumab as a treatment for wet AMD and provides updates on KESTREL and KITE trials for the treatment of diabetic macular edema.
Dissecting ARMOR study data on antibiotic resistance in ophthalmology
December 23, 2021
At the 2021 American Academy of Ophthalmology annual meeting, Penny Asbell, MD, FACS, MBA, discussed data from the ARMOR study and its effects on treating ophthalmic infections, such as endophthalmitis.
Cell therapy emerges as treatment option for corneal endothelial disease
December 20, 2021
New cell therapy drug makes treatment of corneal endothelial disease more accessible.
New sustained-release anti-VEGF formulation EYP-1901 proves safe, effective in phase 1 trials
December 16, 2021
Jay Duker, MD, discusses EYP-1901, EyePoint Pharmaceuticals’ sustained-release anti-VEGF drug for the treatment of wet AMD.
Promising results from phase 2b study of AR-15512 for the treatment of dry eye
December 13, 2021
At AAO 2021, Aerie Pharmaceuticals presented the results of their phase 2b clinical trial of AR-15512, a triple 8 antagonist, for the treatment of dry eye.
Heru addresses gaps in vision care with wearable diagnostic platform
December 09, 2021
Mohamed Abou Shousha, MD, PhD, discusses Heru’s wearable AI-powered diagnostic devices at AAO 2021.
Verana Health unveils new quality measures dashboard at AAO 2021
December 06, 2021
Verana Health showcases the VeraQ quality measures dashboard for the IRIS registry report at AAO 2021.